Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. (Q53987953)

23 May 2018

title

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. (English)

1 reference

23 May 2018

0 references

1 reference

1 reference

Hayashi T

1

1 reference

23 May 2018

Suzuki A

2

1 reference

23 May 2018

Shoji T

3

1 reference

23 May 2018

Togawa M

4

1 reference

23 May 2018

Okada N

5

1 reference

23 May 2018

Tsubakihara Y

6

1 reference

23 May 2018

Imai E

7

1 reference

23 May 2018

Hori M

8

1 reference

23 May 2018

publication date

1 February 2000

1 reference

23 May 2018

American Journal of Kidney Diseases

published in

1 reference

23 May 2018

volume

35

1 reference

23 May 2018

page(s)

250-256

1 reference

23 May 2018

issue

2

1 reference

23 May 2018

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Cardiovascular effects of recombinant human erythropoietin in predialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

A simple method of estimating progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Report on management of renal failure in Europe, XXIV, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Hypertension and cardiovascular effects--long-term safety and potential long-term benefits of r-HuEPO

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Trough-to-peak ratio and 24-hour blood pressure control. Methodologic issues

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

10.1016/S0272-6386(00)70334-9

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

10676724

1 reference

23 May 2018